Bozkaya, Y. Et Al. 2017. The efficacy of modified docetaxel-cisplatin-5-fluorouracil regimen as first-line treatment in patients with alpha-fetoprotein producing gastric carcinoma. Bosnian Journal of Basic Medical Sciences , vol.17, no.2 , 138-143.

Bozkaya, Y., Doğan, M., Yazıcı, O., Erdem, G. U., DEMİRCİ, N. S., & ZENGİN, N., (2017). The efficacy of modified docetaxel-cisplatin-5-fluorouracil regimen as first-line treatment in patients with alpha-fetoprotein producing gastric carcinoma. Bosnian Journal of Basic Medical Sciences , vol.17, no.2, 138-143.

Bozkaya, Yakup Et Al. "The efficacy of modified docetaxel-cisplatin-5-fluorouracil regimen as first-line treatment in patients with alpha-fetoprotein producing gastric carcinoma," Bosnian Journal of Basic Medical Sciences , vol.17, no.2, 138-143, 2017

Bozkaya, Yakup Et Al. "The efficacy of modified docetaxel-cisplatin-5-fluorouracil regimen as first-line treatment in patients with alpha-fetoprotein producing gastric carcinoma." Bosnian Journal of Basic Medical Sciences , vol.17, no.2, pp.138-143, 2017

Bozkaya, Y. Et Al. (2017) . "The efficacy of modified docetaxel-cisplatin-5-fluorouracil regimen as first-line treatment in patients with alpha-fetoprotein producing gastric carcinoma." Bosnian Journal of Basic Medical Sciences , vol.17, no.2, pp.138-143.

@article{article, author={Yakup Bozkaya Et Al. }, title={The efficacy of modified docetaxel-cisplatin-5-fluorouracil regimen as first-line treatment in patients with alpha-fetoprotein producing gastric carcinoma}, journal={Bosnian Journal of Basic Medical Sciences}, year=2017, pages={138-143} }